Seizure detection for epileptic seizures during sleep
NightWatch+ includes a comfortable, wireless sensor that continuously monitors to detect seizures using heart rate and movements while the wearer sleeps. NightWatch+ is intended to be used at home or residential care facilities by people diagnosed with epilepsy aged 4 years and older, having nocturnal epileptic motor seizures and caregivers thereof. When NightWatch+ detects a potentially dangerous seizure, a warning is transmitted via a wireless signal from the sensor to the corresponding alarm station to notify a caregiver.
NightWatch+ seizure detection technology was invented and developed in collaboration with a consortium of Dutch neurologists, patient organizations, universities, and high-tech industries. It comes highly recommended by patients.
Nocturnal epileptic seizures
NightWatch+ detects the following seizure types:
- Tonic-clonic seizures
-
Tonic seizures (clustered or prolonged)
-
Hyperkinetic seizures
-
Myoclonic seizures (clustered)
Clinically proven effective
The Dutch Epilepsy Center SEIN and the Academic Center for Epileptology at Kempenhaeghe validated our detection algorithm technology over thousands of nights. Their findings showed it to be significantly more effective than alternative technologies.
NightWatch+ detects up to 100% of the most dangerous seizures.
NightWatch+
| Audio and visual alarms in the event of a possible epileptic seizure | |
| Ready to use with no configuration required | |
| Alarms can be forwarded to nurse call systems | |
| Free access to the NightWatch portal for seizure monitoring | |
| Maintenance-free for everyday use |
The NightWatch portal
NightWatch+ can connect to the internet, allowing caregivers to access the NightWatch portal with detailed sensor data. This provides valuable insights into how the night went and helps caregivers understand why NightWatch+ issued alarms, if any. Refer to the manual for instructions on how to connect your NightWatch+ to the NightWatch portal.
Try for 30 days
Order NightWatch now and test it for 30 days.
Certification
 |
NightWatch+ is certified as a Class IIa medical device under the EU Medical Device Regulation (MDR) (EU) 2017/745. It has undergone rigorous safety and performance testing and is developed and produced within the Netherlands, according to the ISO 13485 standard. |
Users are advised to carefully read the instructions before using the device for the first time.
